At DeepLife, we use deep learning to create digital twins of cells and predict, in silico, cells reaction to drugs, gene editing or environmental perturbations. With our proprietary technology we save up to 4 years for the identification of molecular triggers driving cells from a sick state to a healthy state. We want to shape the future of bio-engineering, starting today.